The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The gene symbol TLR2 (UniProt accession O60603) correctly identifies human Toll-like receptor 2, a well-characterized pattern recognition receptor belonging to the Toll-like receptor family (colleselli2023anupdateon pages 2-4, chen2024unravelingthecomplexities pages 3-5). The protein contains characteristic leucine-rich repeat (LRR) domains in its extracellular region for ligand recognition and a conserved Toll/interleukin-1 receptor (TIR) domain in its cytoplasmic region for signal transduction, consistent with the UniProt annotation (tang2023tolllikereceptorsand pages 6-8, colleselli2023anupdateon pages 1-2). This verification confirms that the extensive recent literature (2023-2024) on human TLR2 matches the expected protein description and organism.
TLR2 functions as a broadly responsive pattern recognition receptor (PRR) in the innate immune system, serving as a critical sentinel for detecting microbial invasion and tissue damage (colleselli2023anupdateon pages 1-2, chen2024unravelingthecomplexities pages 7-8). Unlike enzymes that catalyze chemical reactions, TLR2 is a signaling receptor that recognizes molecular patterns rather than converting substrates (colleselli2023anupdateon pages 2-4, chen2024unravelingthecomplexities pages 3-5). Its primary role is to detect pathogen-associated molecular patterns (PAMPs) from diverse microorganisms and, in certain contexts, endogenous damage-associated molecular patterns (DAMPs) released during cell stress or injury (colleselli2023anupdateon pages 1-2, colleselli2023anupdateon pages 2-4).
TLR2 exhibits remarkably broad but structurally discriminating ligand specificity that depends critically on its dimerization partners (colleselli2023anupdateon pages 2-4, chen2024unravelingthecomplexities pages 3-5). The receptor does not function in isolation but forms heterodimeric complexes that expand and refine its recognition capacity:
TLR2/TLR1 Heterodimers: This receptor complex preferentially recognizes triacylated lipoproteins and lipopeptides from bacteria (tang2023tolllikereceptorsand pages 8-9, colleselli2023anupdateon pages 2-4). The canonical synthetic agonist is Pam3CSK4, widely used in experimental studies (colleselli2023anupdateon pages 2-4, tominari2024rolesoftolllike pages 1-2). Natural ligands include bacterial lipoarabinomannan and lipomannan from mycobacteria (colleselli2023anupdateon pages 1-2). The structural basis for this specificity involves a hydrophobic channel in TLR1 that accommodates the third acyl chain, enabling discrimination between triacylated and diacylated lipid structures (tang2023tolllikereceptorsand pages 8-9).
TLR2/TLR6 Heterodimers: These complexes recognize diacylated lipopeptides and lipoproteins (tominari2024rolesoftolllike pages 1-2, colleselli2023anupdateon pages 6-7). Key experimental ligands include Pam2CSK4, FSL-1 (modeled on Mycoplasma salivarium lipopeptides), and MALP-2 (colleselli2023anupdateon pages 2-4, colleselli2023anupdateon pages 6-7). Lipoteichoic acid from Gram-positive bacteria is also recognized through TLR2/TLR6 complexes (colleselli2023anupdateon pages 1-2, chu2023interplayofchemokines pages 4-6). TLR6 lacks the hydrophobic pocket present in TLR1, making it structurally suited for diacylated rather than triacylated ligands (tominari2024rolesoftolllike pages 1-2, tang2023tolllikereceptorsand pages 8-9).
TLR2 Homodimers: The formation and functionality of TLR2 homodimers remains controversial in the field (colleselli2023anupdateon pages 2-4, colleselli2023anupdateon pages 6-7). Some studies report that TLR2 homodimers can recognize peptidoglycan and lipoteichoic acid from Gram-positive bacterial cell walls (chu2023interplayofchemokines pages 4-6), but these findings may reflect contaminating lipoproteins in purified preparations rather than direct homodimer-mediated recognition (li2023ctypelectinreceptor pages 1-2). The physiological relevance of TLR2 homodimers appears to depend on specific ligands and potentially unidentified co-receptors (colleselli2023anupdateon pages 2-4).
Additional Receptor Partnerships: Recent research has identified TLR2 heterodimers with TLR10, particularly in recognition of Helicobacter pylori LPS (colleselli2023anupdateon pages 6-7, colleselli2023anupdateon pages 4-6, colleselli2023anupdateon pages 1-2). TLR2/TLR4 heterodimerization has been reported in contexts involving atypical low-endotoxic LPS and host-derived danger signals like hemoglobin, though this mechanism requires further confirmation (colleselli2023anupdateon pages 4-6, colleselli2023anupdateon pages 1-2). Notably, TLR2 can also partner with non-TLR receptors such as CLEC2D (C-type lectin receptor 2D), forming heterodimers that enhance β-glucan binding and negatively regulate IRF5-mediated antifungal immunity (li2023ctypelectinreceptor pages 1-2, li2023ctypelectinreceptor pages 2-3).
Endogenous Danger Signals: Beyond microbial PAMPs, TLR2 responds to host-derived DAMPs including HMGB1, heat shock proteins, human β-defensin-3, and hyaluronan fragments (colleselli2023anupdateon pages 2-4). In neurodegenerative contexts, TLR2 recognizes disease-associated protein aggregates such as Alzheimer's amyloid-β and Parkinson's oligomeric α-synuclein, linking innate immune activation to neuroinflammation (colleselli2023anupdateon pages 2-4, colleselli2023anupdateon pages 12-13).
A comprehensive summary of TLR2 ligand specificity is provided in the table below:
| Receptor complex | Ligand type | Specific examples | Microbial source |
|---|---|---|---|
| TLR2/TLR1 heterodimer | PAMP: triacylated bacterial lipoproteins/lipopeptides | Pam3CSK4; triacylated lipoproteins; lipoarabinomannan and lipomannan. The third lipid chain occupies a hydrophobic channel in TLR1, providing acylation-state specificity. CD14 can facilitate ligand delivery. (colleselli2023anupdateon pages 2-4, colleselli2023anupdateon pages 1-2) | Gram-negative and Gram-positive bacteria, mycobacteria, and Mycoplasma spp. |
| TLR2/TLR6 heterodimer | PAMP: diacylated lipoproteins/lipopeptides | Pam2CSK4, FSL-1, and MALP-2; commonly associated with responses to lipoteichoic-acid-containing preparations. TLR6 lacks the TLR1-like channel for a third acyl chain, favoring diacylated ligands. (colleselli2023anupdateon pages 2-4, tominari2024rolesoftolllike pages 1-2, tang2023tolllikereceptorsand pages 8-9) | Gram-positive bacteria and Mycoplasma spp.; FSL-1 is modeled on a Mycoplasma lipopeptide. |
| TLR2/TLR4 heterodimer or receptor association | PAMP/DAMP: context-dependent and incompletely established | Some atypical, low-endotoxic LPS preparations; hemoglobin and matrix metalloproteinase-2 have also been associated with TLR2/TLR4 signaling. Direct heterodimeric recognition and physiological relevance require further confirmation. (colleselli2023anupdateon pages 4-6, colleselli2023anupdateon pages 1-2) | Reported for atypical bacterial LPS; hemoglobin and MMP-2 are host-derived danger-associated signals rather than microbial products. |
| TLR2/TLR10 heterodimer | PAMP: bacterial surface glycolipids/LPS; specificity remains incompletely defined | Helicobacter pylori LPS and related bacterial signals have been linked to TLR2/TLR10-dependent NF-κB activation and cytokine production, but precise ligand-binding rules remain unresolved. (colleselli2023anupdateon pages 6-7, colleselli2023anupdateon pages 4-6, colleselli2023anupdateon pages 1-2) | Principally reported for Helicobacter pylori. |
| TLR2 homodimer—proposed | PAMP: bacterial cell-wall material | Peptidoglycan and lipoteichoic acid have been assigned to TLR2 homodimers in some studies. However, purified-material responses can reflect contaminating lipoproteins, and the physiological signaling competence of TLR2 homodimers remains controversial. (chu2023interplayofchemokines pages 4-6, colleselli2023anupdateon pages 2-4, li2023ctypelectinreceptor pages 1-2) | Primarily Gram-positive bacterial cell walls. |
| TLR2 homodimer—proposed | PAMP: fungal polysaccharides | Zymosan and β-glucans have been associated with TLR2 responses, often through cooperation with Dectin-1 or other C-type lectin receptors rather than direct recognition by an isolated TLR2 homodimer. (colleselli2023anupdateon pages 12-13, li2023ctypelectinreceptor pages 1-2) | Fungal and yeast cell walls, including Candida and Saccharomyces spp. |
| TLR2 with CLEC2D | PAMP: fungal β-glucans | β-glucans; CLEC2D/TLR2 heterodimers display greater β-glucan-binding ability than TLR2 homodimers and suppress IRF5-mediated IL-12 production through MyD88 degradation. (li2023ctypelectinreceptor pages 1-2, li2023ctypelectinreceptor pages 2-3) | Fungi, experimentally including Candida albicans. |
| TLR2 with accessory receptors | PAMP: structurally diverse microbial particles | Zymosan and β-glucans with Dectin-1; selected diacylated ligands with CD36; bacterial lipopeptides presented by CD14. CD14, CD36, CD44, integrins, and lectin receptors can control delivery, avidity, or signaling rather than replace the canonical TLR partner. (colleselli2023anupdateon pages 1-2, colleselli2023anupdateon pages 4-6, li2023ctypelectinreceptor pages 1-2) | Bacteria, fungi, and yeasts, depending on the accessory receptor and ligand. |
| TLR2 complex; partner context-dependent or unresolved | DAMP: extracellular host proteins and matrix fragments | HMGB1, heat-shock proteins, human β-defensin-3, and hyaluronan fragments. These are proposed endogenous danger signals, but direct binding and exclusion of microbial contaminants are not equally established for every candidate. (colleselli2023anupdateon pages 2-4) | None—released, exposed, or fragmented during host-cell stress, injury, or inflammation. |
| TLR2 complex; partner context-dependent or unresolved | DAMP: disease-associated protein aggregates | Amyloid-β and oligomeric α-synuclein, associated with microglial or inflammatory activation in neurodegenerative settings. (colleselli2023anupdateon pages 2-4, colleselli2023anupdateon pages 12-13) | None—host-derived aggregates associated with Alzheimer’s and Parkinson’s disease biology. |
Table: TLR2 recognizes molecular patterns rather than catalyzing a substrate reaction; receptor partners and accessory proteins determine much of its specificity. The table distinguishes well-established lipopeptide recognition from proposed or context-dependent PAMP and DAMP assignments.
TLR2 is predominantly expressed at the plasma membrane, where it functions as a cell-surface pattern recognition receptor (tang2023tolllikereceptorsand pages 6-8, chen2024unravelingthecomplexities pages 3-5, tominari2024rolesoftolllike pages 6-7). As a type I transmembrane protein, its extracellular leucine-rich repeat domain extends into the extracellular space to encounter microbial ligands, while its transmembrane domain anchors it in the plasma membrane and its cytoplasmic TIR domain initiates intracellular signaling (colleselli2023anupdateon pages 1-2, colleselli2023anupdateon pages 2-4). This surface localization enables TLR2 to detect extracellular threats and initiate rapid innate immune responses (chen2024unravelingthecomplexities pages 3-5, chen2024unravelingthecomplexities pages 2-3).
While cell-surface localization is primary, TLR2 is not restricted to the plasma membrane (colleselli2023anupdateon pages 6-7). In human monocytes, TLR2 has been detected in early endosomes, late endosomes/lysosomes, and Rab11-positive recycling compartments, but not in the Golgi apparatus or endoplasmic reticulum (colleselli2023anupdateon pages 6-7). These intracellular pools can mediate functionally distinct responses: endosomal TLR2 has been associated with immune-suppressive signaling, particularly TLR2-dependent IL-10 production during Listeria monocytogenes infection (colleselli2023anupdateon pages 6-7). This compartmentalization allows TLR2 to generate context-dependent pro-inflammatory or regulatory outputs depending on the cellular location of ligand encounter (colleselli2023anupdateon pages 6-7).
Beyond membrane-bound forms, TLR2 exists in soluble forms generated through proteolytic shedding of the extracellular receptor domain (colleselli2023anupdateon pages 6-7). Additionally, full-length TLR2 can be released by macrophages in extracellular vesicles under anti-inflammatory conditions (colleselli2023anupdateon pages 6-7). These soluble and vesicle-associated TLR2 molecules may function as decoys, sequestering ligands and contributing to immune suppression (colleselli2023anupdateon pages 6-7).
TLR2 is expressed across diverse cell types, including immune cells such as monocytes, macrophages, dendritic cells, neutrophils, and lymphocytes, as well as non-immune cells including endothelial cells, epithelial cells, and platelets (colleselli2023anupdateon pages 1-2, tang2023tolllikereceptorsand pages 6-8). This broad distribution enables TLR2-mediated immune surveillance in multiple tissues and compartments throughout the body (colleselli2023anupdateon pages 1-2).
TLR2 signals primarily through the MyD88-dependent pathway, which represents the canonical route for most TLR2-mediated responses (colleselli2023anupdateon pages 2-4, mantovani2023tlrsinnateimmune pages 3-4, tang2023tolllikereceptorsand pages 6-8). The signaling cascade proceeds as follows:
1. Ligand-Induced Dimerization: Ligand binding stabilizes TLR2 heterodimers (typically TLR2/TLR1 or TLR2/TLR6), bringing the cytoplasmic TIR domains into close proximity (colleselli2023anupdateon pages 2-4). This creates a docking platform for adaptor proteins (colleselli2023anupdateon pages 2-4).
2. Adaptor Recruitment: The sorting adaptor TIRAP (TIR domain-containing adaptor protein), also known as MAL (MyD88-adaptor-like), is recruited to the activated receptor complex at phosphoinositide-rich membrane regions (colleselli2023anupdateon pages 2-4, lannoy2023tiraptramand pages 2-3). TIRAP facilitates efficient MyD88 recruitment, though TLR2 signaling can proceed with delayed kinetics in TIRAP's absence (lannoy2023tiraptramand pages 2-3).
3. Myddosome Assembly: MyD88 provides a death-domain scaffold that recruits the kinase IRAK4 (IL-1R-associated kinase 4), which in turn activates IRAK1 and IRAK2, forming the "myddosome" complex (colleselli2023anupdateon pages 2-4, lannoy2023tiraptramand pages 1-2, tang2023tolllikereceptorsand pages 6-8). This represents a key amplification step in TLR2 signaling.
4. TRAF6 Activation: Activated IRAKs engage TRAF6 (TNF receptor-associated factor 6), which undergoes K63-linked auto-ubiquitination and ubiquitinates NEMO/IKKγ (colleselli2023anupdateon pages 2-4). These non-degradative ubiquitin chains create signaling scaffolds that recruit downstream effectors.
5. TAK1 Activation: The ubiquitin scaffolds recruit the TAB2/TAB3-TAK1 (transforming growth factor-β-activated kinase 1) complex, activating TAK1 kinase activity (colleselli2023anupdateon pages 2-4, tang2023tolllikereceptorsand pages 6-8). TAK1 serves as a critical branch point for both NF-κB and MAPK pathway activation.
6. NF-κB Pathway: TAK1 phosphorylates and activates the IKK complex (IKKα, IKKβ, NEMO), which phosphorylates IκB proteins, targeting them for proteasomal degradation (colleselli2023anupdateon pages 2-4, mantovani2023tlrsinnateimmune pages 3-4). This releases NF-κB dimers (primarily RelA/p50) for nuclear translocation and transcriptional activation of inflammatory genes including TNF, IL1B, IL6, and chemokines (colleselli2023anupdateon pages 2-4, colleselli2023anupdateon pages 6-7).
7. MAPK and AP-1 Pathways: TAK1 also activates mitogen-activated protein kinase (MAPK) cascades, including p38, JNK, and ERK1/2 (chu2023interplayofchemokines pages 4-6, tang2023tolllikereceptorsand pages 6-8, tang2023tolllikereceptorsand pages 8-9). These pathways activate AP-1 transcription factors and cooperate with NF-κB to drive inflammatory gene expression (chu2023interplayofchemokines pages 4-6, lannoy2023tiraptramand pages 2-3).
PI3K-AKT Pathway: TLR2, particularly through TLR2/TLR6 heterodimers, activates phosphoinositide 3-kinase (PI3K) and AKT signaling (chu2023interplayofchemokines pages 4-6). This pathway can intersect with RAC1 and ERK signaling to modulate inflammatory responses, cell survival, migration, and adhesion (chu2023interplayofchemokines pages 4-6).
TPL2/MAP3K8 Pathway: TLR2 activates the kinase TPL2 (also known as MAP3K8), which branches into IKK2-NF-κB and MEK1/2-ERK1/2 cascades (chu2023interplayofchemokines pages 4-6). This provides an alternative route to inflammatory transcription factor activation.
TRIF-Independent Signaling: Unlike TLR4, which can signal through both MyD88-dependent and TRIF-dependent pathways, TLR2 lacks the TRIF-dependent branch (tang2023tolllikereceptorsand pages 6-8, tang2023tolllikereceptorsand pages 8-9). Consequently, TLR2 does not typically induce the robust type I interferon responses characteristic of TRIF-dependent signaling, although some interferon production has been reported in specific contexts (colleselli2023anupdateon pages 6-7).
A detailed stepwise summary of TLR2 signaling is presented in the table below:
| Signaling component/step | Molecular players | Function/role | Downstream effect |
|---|---|---|---|
| 1. Extracellular ligand recognition | TLR2 extracellular leucine-rich-repeat domain; microbial lipoproteins/lipopeptides; accessory receptors CD14, CD36, CD44, and integrins | Detects extracellular pathogen-associated molecular patterns; accessory receptors can capture or present ligands to TLR2 complexes. TLR2 is a pattern-recognition signaling receptor, not an enzyme, so ligands are recognized rather than chemically converted. (colleselli2023anupdateon pages 1-2, colleselli2023anupdateon pages 4-6) | Initiates ligand-dependent receptor assembly and determines signaling strength and specificity. |
| 2. Partner-specific recognition | TLR2–TLR1; TLR2–TLR6 | TLR2–TLR1 preferentially recognizes triacylated lipopeptides such as Pam3CSK4, whereas TLR2–TLR6 recognizes diacylated lipopeptides such as Pam2CSK4, FSL-1, and MALP-2. (tominari2024rolesoftolllike pages 1-2, colleselli2023anupdateon pages 2-4, li2023ctypelectinreceptor pages 1-2) | Broadens microbial recognition while discriminating lipid-acylation patterns. |
| 3. Receptor dimerization | TLR2 with TLR1 or TLR6; context-dependent TLR2–TLR10, TLR2–TLR4, CLEC2D–TLR2, and possible TLR2 homodimers | Ligand binding stabilizes extracellular receptor association and brings cytoplasmic TIR domains into proximity. TLR2–TLR1 and TLR2–TLR6 are best established; physiological TLR2 homodimer signaling remains controversial. (colleselli2023anupdateon pages 4-6, colleselli2023anupdateon pages 2-4, li2023ctypelectinreceptor pages 2-3) | Creates an intracellular docking platform for signaling adaptors. |
| 4. Sorting-adaptor recruitment | TIRAP/MAL; phosphoinositide-rich plasma-membrane regions | TIRAP binds the activated receptor complex and facilitates recruitment of MyD88. TIRAP loss impairs cytokine production and delays, rather than necessarily abolishes, NF-κB activation. (colleselli2023anupdateon pages 2-4, lannoy2023tiraptramand pages 2-3) | Enables efficient spatial assembly of the proximal TLR2 signaling complex. |
| 5. Myddosome assembly | MyD88, IRAK4, IRAK1, IRAK2 | MyD88 provides a death-domain scaffold that recruits IRAK kinases; IRAK4 activates IRAK1/2 within the myddosome. TLR2 signaling is principally MyD88-dependent rather than TRIF-dependent. (colleselli2023anupdateon pages 2-4, tang2023tolllikereceptorsand pages 6-8, tang2023tolllikereceptorsand pages 8-9) | Converts receptor engagement into an amplified kinase and ubiquitin-signaling cascade. |
| 6. TRAF6 activation and ubiquitin scaffolding | IRAK1/2, TRAF6, K63-linked polyubiquitin, NEMO/IKKγ | Activated IRAKs engage TRAF6; TRAF6-dependent K63-linked ubiquitination creates non-degradative signaling scaffolds and promotes NEMO ubiquitination. (colleselli2023anupdateon pages 2-4, lannoy2023tiraptramand pages 1-2) | Recruits and activates TAK1 and the IKK/MAPK signaling modules. |
| 7. TAK1 activation | TAK1/MAP3K7, TAB2, TAB3 | TAB proteins recognize ubiquitin scaffolds and support TAK1 activation, forming a branch point between NF-κB and MAPK signaling. (colleselli2023anupdateon pages 2-4, tang2023tolllikereceptorsand pages 6-8) | Activates the IKK complex and MAPK cascades. |
| 8. Canonical NF-κB pathway | IKKα, IKKβ, NEMO, IκB, NF-κB RelA/p50 | IKK-mediated phosphorylation targets IκB for degradation, releasing NF-κB for nuclear translocation. (colleselli2023anupdateon pages 2-4, mantovani2023tlrsinnateimmune pages 3-4) | Induces inflammatory genes, including TNF, IL6, IL1B, chemokines, adhesion molecules, and other innate-defense mediators. |
| 9. MAPK and AP-1 pathways | p38, JNK, ERK1/2, AP-1, MEK1/2, TPL2/MAP3K8 | TAK1 and TPL2 activate MAPK branches; MAPKs regulate AP-1 and cooperate with NF-κB in inflammatory transcription, cellular activation, survival, and proliferation. (chu2023interplayofchemokines pages 4-6, lannoy2023tiraptramand pages 2-3, tang2023tolllikereceptorsand pages 6-8) | Promotes cytokine and chemokine production and alters activation, survival, migration, and inflammatory phenotype. |
| 10. Alternative PI3K–AKT signaling | PI3K, AKT, RAC1, ERK1/2 | Particularly reported downstream of TLR2–TLR6; intersects with RAC1 and ERK signaling and can modify inflammatory, survival, migration, and cell-type-specific responses. (chu2023interplayofchemokines pages 4-6) | Context-dependent modulation of NF-κB/MAPK output, cell survival, cytoskeletal behavior, adhesion, and migration. |
| 11. Compartment-dependent signaling | Internalized TLR2; early and late endosomes, lysosomes, Rab11-positive compartments | Although TLR2 functions primarily at the plasma membrane, intracellular pools can generate qualitatively different responses. Endosomal TLR2 has been associated with regulatory signaling and, in some infection contexts, interferon-related responses. (colleselli2023anupdateon pages 6-7, lannoy2023tiraptramand pages 1-2) | Produces context-dependent antimicrobial, regulatory, or anti-inflammatory outputs, including TLR2-dependent IL-10 in some infections. |
| 12. Principal inflammatory outputs | TNF-α, IL-1α/β, IL-6, IL-8/CXCL8, IL-12, CXCL10, and other chemokines | NF-κB, AP-1, and MAPKs drive a coordinated inflammatory transcriptional program. The exact output depends on ligand, dimer partner, cell type, co-receptors, and cellular compartment. (colleselli2023anupdateon pages 6-7, tang2023tolllikereceptorsand pages 6-8) | Supports leukocyte recruitment and activation, antimicrobial defense, dendritic-cell maturation, endothelial activation, and coordination of adaptive immunity. |
| 13. Regulatory and anti-inflammatory outputs | IL-10, IFN-γ; soluble or extracellular-vesicle-associated TLR2 | Certain ligands and compartments produce regulatory rather than classically inflammatory signaling; soluble TLR2 may sequester ligand or act as a decoy. (colleselli2023anupdateon pages 6-7) | Promotes immune tolerance or suppression, limits excessive inflammation, and modulates host–microbiota interactions. |
| 14. Functional cellular consequences | Monocytes, macrophages, dendritic cells, epithelial and endothelial cells, platelets | TLR2 signaling influences cytokine production, antimicrobial peptide expression, antigen presentation, monocyte adhesion and migration, endothelial-barrier disruption, coagulation, and platelet–leukocyte interactions. (chen2024unravelingthecomplexities pages 7-8, colleselli2023anupdateon pages 6-7, colleselli2023beyondpatternrecognition pages 7-9) | Supports pathogen defense when controlled but can cause chronic inflammation, vascular injury, thrombosis, or tissue damage when excessive or persistent. |
Table: Stepwise summary of canonical and alternative TLR2 signaling from ligand recognition and receptor dimerization through MyD88–IRAK–TRAF6 signaling, transcription-factor activation, and inflammatory or regulatory outputs.
TLR2 plays a central role in innate immune responses against diverse pathogens (colleselli2023anupdateon pages 1-2, chu2023interplayofchemokines pages 4-6, chen2024unravelingthecomplexities pages 7-8). Through its broad ligand recognition capacity, TLR2 contributes to host defense against:
TLR2 activation drives production of a comprehensive suite of inflammatory mediators (colleselli2023anupdateon pages 6-7, mantovani2023tlrsinnateimmune pages 3-4, tang2023tolllikereceptorsand pages 6-8):
Pro-inflammatory cytokines: TNF-α, IL-1α, IL-1β, IL-6, IL-12 (colleselli2023anupdateon pages 6-7, chu2023interplayofchemokines pages 4-6)
Chemokines: IL-8/CXCL8, CXCL10/IP-10, CCL2/MCP-1 (colleselli2023anupdateon pages 6-7, kappagoda2024roleoftolllike pages 6-7)
Type I and II interferons: IFN-α, IFN-β, IFN-γ (context-dependent) (colleselli2023anupdateon pages 6-7)
Antimicrobial peptides: human β-defensin-2 (hBD2) (kappagoda2024roleoftolllike pages 8-9)
These mediators coordinate leukocyte recruitment, activation of adaptive immunity, antimicrobial defense, and inflammatory tissue responses (tang2023tolllikereceptorsand pages 6-8, chen2024unravelingthecomplexities pages 7-8, chu2023interplayofchemokines pages 4-6).
TLR2 activation influences the polarization of T helper cell responses (chu2023interplayofchemokines pages 4-6). TLR2 is associated with TH2 immunity, supporting host defense against helminths and insects through production of IL-4, IL-25, and IL-33 (chu2023interplayofchemokines pages 4-6). TLR2 also contributes to TH22 responses against extracellular bacteria and fungi, promoting IL-1, IL-6, and TNF-α production (chu2023interplayofchemokines pages 4-6).
Recent research has revealed that TLR2 influences cellular processes beyond classical pattern recognition (colleselli2023anupdateon pages 6-7):
Cell Adhesion and Migration: TLR2 promotes monocyte chemotaxis, cell adhesion to activated endothelium, and transendothelial migration (colleselli2023anupdateon pages 6-7). Experimental evidence using TLR2-knockout and TLR2-knockin THP-1 cells demonstrated that TLR2 enhances rapid and strong monocyte adhesion and increases endothelial barrier disruption (colleselli2023beyondpatternrecognition pages 7-9, colleselli2023anupdateon pages 6-7).
Vascular and Hemostatic Responses: TLR2 activation induces tissue factor expression, participates in the extrinsic coagulation pathway, promotes platelet recruitment, and facilitates platelet-monocyte aggregate formation (colleselli2023anupdateon pages 6-7). TLR2 is expressed on platelets and megakaryocytes, linking innate immune recognition to thrombosis and hemostasis (tang2023tolllikereceptorsand pages 8-9, tang2023tolllikereceptorsand pages 6-8).
Dendritic Cell Maturation: TLR2 signaling promotes dendritic cell maturation, enhancing antigen presentation and T cell activation, thereby bridging innate and adaptive immunity (chen2024unravelingthecomplexities pages 7-8, cossu2023theroleof pages 2-4).
While TLR2 is primarily pro-inflammatory, it can also mediate anti-inflammatory or regulatory responses depending on ligand, cell type, and cellular compartment (colleselli2023anupdateon pages 6-7). Examples include:
This dual pro- and anti-inflammatory capacity allows TLR2 to participate in both pathogen clearance and immune homeostasis (colleselli2023anupdateon pages 7-9, colleselli2023anupdateon pages 6-7).
Multiple lines of experimental evidence support TLR2 function in human cells:
Engineered Cell Models: HEK293 cells expressing human TLR2 demonstrate receptor-dependent inflammatory responses to Leptospira components, with increased expression of CXCL8/IL-8, CCL2/MCP-1, and TNF-α (kappagoda2024roleoftolllike pages 6-7). TLR2-mediated p38 phosphorylation and chemokine release have been documented in these systems (kappagoda2024roleoftolllike pages 6-7).
Primary Human Monocytes and Macrophages: THP-1 monocytic cells with wild-type, TLR2-knockout, and TLR2-knock-in alleles show TLR2-dependent differences in adhesion, migration, and endothelial activation (colleselli2023beyondpatternrecognition pages 7-9, colleselli2023anupdateon pages 6-7). Human alveolar macrophages show strong TLR2 mRNA induction following prolonged LPS exposure (colleselli2023anupdateon pages 1-2, colleselli2023anupdateon pages 2-4).
Human Epithelial Cells: Human kidney epithelial HK2 cells infected with Leptospira interrogans demonstrate TLR2-dependent induction of antimicrobial and inflammatory genes, including hBD2, IL-1β, IL-6, IL-8, and TNF-α (kappagoda2024roleoftolllike pages 8-9). Anti-TLR2 antibody blockade significantly reduces these responses (kappagoda2024roleoftolllike pages 8-9).
Human Blood Models: Whole blood from healthy human donors stimulated with Leptospira shows TLR2-dependent TNF-α and IL-6 production, with antibody-mediated TLR2 blockade reducing cytokine levels (kappagoda2024roleoftolllike pages 5-6).
Evidence from human tissues supports in vivo TLR2 function:
Kidney Tissue: Human renal proximal tubular cells from both healthy individuals and leptospirosis patients demonstrate TLR2- and MyD88-mediated fibronectin production in response to Leptospira exposure (kappagoda2024roleoftolllike pages 7-8). Fibronectin immunostaining is markedly stronger in kidneys from infected patients (kappagoda2024roleoftolllike pages 7-8).
Lung Tissue: Human lung tissue from patients who died of leptospirosis shows increased TLR2 expression by immunohistochemistry, with sustained TLR2 localization in endothelial cells of small pulmonary vessels (kappagoda2024roleoftolllike pages 7-8).
These human-derived experimental systems provide robust evidence for TLR2-mediated pathogen recognition, inflammatory signaling, and immune responses in physiologically relevant contexts.
Recent comprehensive reviews have clarified several aspects of TLR2 biology:
Dimerization Mechanisms: While TLR2/TLR1 and TLR2/TLR6 heterodimers are well-established, the field has made progress in understanding how ligand binding stabilizes these complexes through extracellular domain interactions (colleselli2023anupdateon pages 4-6, li2023ctypelectinreceptor pages 1-2). The discovery of TLR2/CLEC2D heterodimers adds complexity to TLR2's receptor partnerships (li2023ctypelectinreceptor pages 1-2, li2023ctypelectinreceptor pages 2-3).
Compartment-Specific Signaling: The recognition that TLR2 functions not only at the cell surface but also in endosomal compartments, with distinct functional outcomes, represents an important refinement of the classical view (colleselli2023anupdateon pages 6-7).
Therapeutic Implications: TLR2 has emerged as a potential therapeutic target in multiple diseases, including infectious diseases, autoimmune disorders, neurodegenerative diseases, and cancer (colleselli2023anupdateon pages 2-4, chen2024unravelingthecomplexities pages 3-5). Both TLR2 agonists (for vaccine adjuvants and immunotherapy) and antagonists (for anti-inflammatory therapy) are under investigation.
Disease Associations: TLR2 has been implicated in diverse pathological contexts including atherosclerosis, inflammatory bone resorption, Parkinson's disease, COVID-19 severity, and cancer progression, highlighting both its protective and potentially pathogenic roles depending on context (colleselli2023anupdateon pages 2-4, colleselli2023anupdateon pages 7-9).
TLR2 (UniProt O60603) is a versatile pattern recognition receptor that serves as a critical sentinel of innate immunity in humans. As a signaling receptor rather than an enzyme, TLR2 recognizes diverse molecular patterns through ligand-dependent heterodimerization, primarily with TLR1 or TLR6, enabling discrimination between triacylated and diacylated bacterial lipopeptides. The receptor functions predominantly at the cell surface but also operates in intracellular compartments with context-dependent outcomes.
TLR2 signals primarily through the MyD88-dependent pathway, recruiting TIRAP and MyD88 adaptors, activating IRAK kinases and TRAF6, and ultimately driving NF-κB and MAPK-mediated inflammatory gene expression. The resulting production of cytokines (TNF-α, IL-1, IL-6, IL-12), chemokines (IL-8, CXCL10, CCL2), and antimicrobial peptides coordinates innate immune defense against bacteria, fungi, and other pathogens.
Beyond classical pattern recognition, TLR2 influences cell adhesion, migration, endothelial activation, dendritic cell maturation, and hemostatic responses, positioning it as a multifunctional regulator of innate immunity and inflammation. The receptor's ability to mediate both pro-inflammatory and regulatory responses depending on cellular context reflects the sophisticated balance required for effective host defense without excessive tissue damage.
Experimental evidence from human cells, tissues, and blood models provides robust support for TLR2's functional roles in pathogen recognition, inflammatory signaling, and immune coordination. Recent research (2023-2024) continues to refine our understanding of TLR2's dimerization mechanisms, compartment-specific signaling, and therapeutic potential across diverse disease contexts.
References
(colleselli2023anupdateon pages 2-4): Katrin Colleselli, Anna Stierschneider, and Christoph Wiesner. An update on toll-like receptor 2, its function and dimerization in pro- and anti-inflammatory processes. International Journal of Molecular Sciences, 24:12464, Aug 2023. URL: https://doi.org/10.3390/ijms241512464, doi:10.3390/ijms241512464. This article has 110 citations.
(chen2024unravelingthecomplexities pages 3-5): Yi-Hsin Chen, Kang-Hsi Wu, and Han-Ping Wu. Unraveling the complexities of toll-like receptors: from molecular mechanisms to clinical applications. May 2024. URL: https://doi.org/10.3390/ijms25095037, doi:10.3390/ijms25095037. This article has 98 citations.
(tang2023tolllikereceptorsand pages 6-8): Xiaoqing Tang, Qian Xu, Shuo Yang, Xinwu Huang, Long Wang, Feihong Huang, Jiesi Luo, Xiaogang Zhou, Anguo Wu, Qibing Mei, Chunling Zhao, and Jianming Wu. Toll-like receptors and thrombopoiesis. International Journal of Molecular Sciences, 24:1010, Jan 2023. URL: https://doi.org/10.3390/ijms24021010, doi:10.3390/ijms24021010. This article has 42 citations.
(colleselli2023anupdateon pages 1-2): Katrin Colleselli, Anna Stierschneider, and Christoph Wiesner. An update on toll-like receptor 2, its function and dimerization in pro- and anti-inflammatory processes. International Journal of Molecular Sciences, 24:12464, Aug 2023. URL: https://doi.org/10.3390/ijms241512464, doi:10.3390/ijms241512464. This article has 110 citations.
(chen2024unravelingthecomplexities pages 7-8): Yi-Hsin Chen, Kang-Hsi Wu, and Han-Ping Wu. Unraveling the complexities of toll-like receptors: from molecular mechanisms to clinical applications. May 2024. URL: https://doi.org/10.3390/ijms25095037, doi:10.3390/ijms25095037. This article has 98 citations.
(tang2023tolllikereceptorsand pages 8-9): Xiaoqing Tang, Qian Xu, Shuo Yang, Xinwu Huang, Long Wang, Feihong Huang, Jiesi Luo, Xiaogang Zhou, Anguo Wu, Qibing Mei, Chunling Zhao, and Jianming Wu. Toll-like receptors and thrombopoiesis. International Journal of Molecular Sciences, 24:1010, Jan 2023. URL: https://doi.org/10.3390/ijms24021010, doi:10.3390/ijms24021010. This article has 42 citations.
(tominari2024rolesoftolllike pages 1-2): Tsukasa Tominari, Chiho Matsumoto, Yuki Tanaka, Kensuke Shimizu, Masaru Takatoya, Moe Sugasaki, Kento Karouji, Urara Kasuga, Chisato Miyaura, Shinji Miyata, Yoshifumi Itoh, Michiko Hirata, and Masaki Inada. Roles of toll-like receptor signaling in inflammatory bone resorption. Biology, 13:692, Sep 2024. URL: https://doi.org/10.3390/biology13090692, doi:10.3390/biology13090692. This article has 49 citations.
(colleselli2023anupdateon pages 6-7): Katrin Colleselli, Anna Stierschneider, and Christoph Wiesner. An update on toll-like receptor 2, its function and dimerization in pro- and anti-inflammatory processes. International Journal of Molecular Sciences, 24:12464, Aug 2023. URL: https://doi.org/10.3390/ijms241512464, doi:10.3390/ijms241512464. This article has 110 citations.
(chu2023interplayofchemokines pages 4-6): Yuan-Tung Chu, Min-Tser Liao, Kuo-Wang Tsai, Kuo-Cheng Lu, and Wan-Chung Hu. Interplay of chemokines receptors, toll-like receptors, and host immunological pathways. Biomedicines, 11:2384, Aug 2023. URL: https://doi.org/10.3390/biomedicines11092384, doi:10.3390/biomedicines11092384. This article has 34 citations.
(li2023ctypelectinreceptor pages 1-2): Fan Li, Hui Wang, Yan-Qi Li, Yebo Gu, and Xin-Ming Jia. C-type lectin receptor 2d forms homodimers and heterodimers with tlr2 to negatively regulate irf5-mediated antifungal immunity. Nature Communications, Oct 2023. URL: https://doi.org/10.1038/s41467-023-42216-3, doi:10.1038/s41467-023-42216-3. This article has 35 citations and is from a highest quality peer-reviewed journal.
(colleselli2023anupdateon pages 4-6): Katrin Colleselli, Anna Stierschneider, and Christoph Wiesner. An update on toll-like receptor 2, its function and dimerization in pro- and anti-inflammatory processes. International Journal of Molecular Sciences, 24:12464, Aug 2023. URL: https://doi.org/10.3390/ijms241512464, doi:10.3390/ijms241512464. This article has 110 citations.
(li2023ctypelectinreceptor pages 2-3): Fan Li, Hui Wang, Yan-Qi Li, Yebo Gu, and Xin-Ming Jia. C-type lectin receptor 2d forms homodimers and heterodimers with tlr2 to negatively regulate irf5-mediated antifungal immunity. Nature Communications, Oct 2023. URL: https://doi.org/10.1038/s41467-023-42216-3, doi:10.1038/s41467-023-42216-3. This article has 35 citations and is from a highest quality peer-reviewed journal.
(colleselli2023anupdateon pages 12-13): Katrin Colleselli, Anna Stierschneider, and Christoph Wiesner. An update on toll-like receptor 2, its function and dimerization in pro- and anti-inflammatory processes. International Journal of Molecular Sciences, 24:12464, Aug 2023. URL: https://doi.org/10.3390/ijms241512464, doi:10.3390/ijms241512464. This article has 110 citations.
(tominari2024rolesoftolllike pages 6-7): Tsukasa Tominari, Chiho Matsumoto, Yuki Tanaka, Kensuke Shimizu, Masaru Takatoya, Moe Sugasaki, Kento Karouji, Urara Kasuga, Chisato Miyaura, Shinji Miyata, Yoshifumi Itoh, Michiko Hirata, and Masaki Inada. Roles of toll-like receptor signaling in inflammatory bone resorption. Biology, 13:692, Sep 2024. URL: https://doi.org/10.3390/biology13090692, doi:10.3390/biology13090692. This article has 49 citations.
(chen2024unravelingthecomplexities pages 2-3): Yi-Hsin Chen, Kang-Hsi Wu, and Han-Ping Wu. Unraveling the complexities of toll-like receptors: from molecular mechanisms to clinical applications. May 2024. URL: https://doi.org/10.3390/ijms25095037, doi:10.3390/ijms25095037. This article has 98 citations.
(mantovani2023tlrsinnateimmune pages 3-4): Stefania Mantovani, Barbara Oliviero, Stefania Varchetta, Alessandra Renieri, and Mario U. Mondelli. Tlrs: innate immune sentries against sars-cov-2 infection. International Journal of Molecular Sciences, 24:8065, Apr 2023. URL: https://doi.org/10.3390/ijms24098065, doi:10.3390/ijms24098065. This article has 84 citations.
(lannoy2023tiraptramand pages 2-3): Valérie Lannoy, Anthony Côté-Biron, Claude Asselin, and Nathalie Rivard. Tirap, tram, and toll-like receptors: the untold story. Mediators of Inflammation, 2023:1-13, Mar 2023. URL: https://doi.org/10.1155/2023/2899271, doi:10.1155/2023/2899271. This article has 61 citations and is from a peer-reviewed journal.
(lannoy2023tiraptramand pages 1-2): Valérie Lannoy, Anthony Côté-Biron, Claude Asselin, and Nathalie Rivard. Tirap, tram, and toll-like receptors: the untold story. Mediators of Inflammation, 2023:1-13, Mar 2023. URL: https://doi.org/10.1155/2023/2899271, doi:10.1155/2023/2899271. This article has 61 citations and is from a peer-reviewed journal.
(colleselli2023beyondpatternrecognition pages 7-9): Katrin Colleselli, Marie Ebeyer-Masotta, Benjamin Neuditschko, Anna Stierschneider, Christopher Pollhammer, Mia Potocnjak, Harald Hundsberger, Franz Herzog, and Christoph Wiesner. Beyond pattern recognition: tlr2 promotes chemotaxis, cell adhesion, and migration in thp-1 cells. Cells, 12:1425, May 2023. URL: https://doi.org/10.3390/cells12101425, doi:10.3390/cells12101425. This article has 10 citations.
(colleselli2023anupdateon pages 7-9): Katrin Colleselli, Anna Stierschneider, and Christoph Wiesner. An update on toll-like receptor 2, its function and dimerization in pro- and anti-inflammatory processes. International Journal of Molecular Sciences, 24:12464, Aug 2023. URL: https://doi.org/10.3390/ijms241512464, doi:10.3390/ijms241512464. This article has 110 citations.
(kappagoda2024roleoftolllike pages 6-7): Chamila Kappagoda, Indika Senavirathna, Thilini Agampodi, and Suneth Buddhika Agampodi. Role of toll-like receptor 2 during infection of leptospira spp: a systematic review. PLOS ONE, 19:e0312466, Dec 2024. URL: https://doi.org/10.1371/journal.pone.0312466, doi:10.1371/journal.pone.0312466. This article has 3 citations and is from a peer-reviewed journal.
(kappagoda2024roleoftolllike pages 8-9): Chamila Kappagoda, Indika Senavirathna, Thilini Agampodi, and Suneth Buddhika Agampodi. Role of toll-like receptor 2 during infection of leptospira spp: a systematic review. PLOS ONE, 19:e0312466, Dec 2024. URL: https://doi.org/10.1371/journal.pone.0312466, doi:10.1371/journal.pone.0312466. This article has 3 citations and is from a peer-reviewed journal.
(cossu2023theroleof pages 2-4): Chiara Cossu, Antonino Di Lorenzo, Irene Fiorilla, Alberto Maria Todesco, Valentina Audrito, and Laura Conti. The role of the toll-like receptor 2 and the cgas-sting pathways in breast cancer: friends or foes? International Journal of Molecular Sciences, 25:456, Dec 2023. URL: https://doi.org/10.3390/ijms25010456, doi:10.3390/ijms25010456. This article has 21 citations.
(kappagoda2024roleoftolllike pages 5-6): Chamila Kappagoda, Indika Senavirathna, Thilini Agampodi, and Suneth Buddhika Agampodi. Role of toll-like receptor 2 during infection of leptospira spp: a systematic review. PLOS ONE, 19:e0312466, Dec 2024. URL: https://doi.org/10.1371/journal.pone.0312466, doi:10.1371/journal.pone.0312466. This article has 3 citations and is from a peer-reviewed journal.
(kappagoda2024roleoftolllike pages 7-8): Chamila Kappagoda, Indika Senavirathna, Thilini Agampodi, and Suneth Buddhika Agampodi. Role of toll-like receptor 2 during infection of leptospira spp: a systematic review. PLOS ONE, 19:e0312466, Dec 2024. URL: https://doi.org/10.1371/journal.pone.0312466, doi:10.1371/journal.pone.0312466. This article has 3 citations and is from a peer-reviewed journal.